Giovanni Leo
Partner @ Efficient Frontier Investing
Geneva, Switzerland
Giovanni Leo is a seed investor at Efficient Frontier Investing in Geneva focused on Health Care and Medical Device. Giovanni Leo is the Partner at Efficient Frontier Investing.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 40%
Last updated:
For AI agents: llms.txt
Industries Giovanni Leo invests in
Stages Giovanni Leo invests in
Countries Giovanni Leo invests in
Round sizes
Round size
- Series B
- $4M–$5.1M
Investment Focus
Industry
- Health Care 4 (80%)
- Medical Device 3 (60%)
- Medical 2 (40%)
- Navigation 1 (20%)
- Biotechnology 1 (20%)
Stage
- Seed 2 (40%)
- Series B 2 (40%)
- Series A 1 (20%)
Country
- Switzerland 4 (80%)
- Italy 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Hylomorph
|
Hylomorph is a MedTech company that specializes in providing fibrotic encapsulation solutions in implantable medical devices. The company was founded in 2014 and is headquartered in Zurich, Switzerland. | $5.1M / Series B / Sep 05, 2023 | |
EBAMed
|
EBAMed SA is a Swiss startup based in Geneva whose mission is to enable safe and effective non-invasive treatments of heart arrhythmias with protontherapy. The company is currently developing a medical device to enable non-invasive heart motion imaging and real-time synchronization of the therapeutic beam. This device consists in both hardware andsoftware components and expands treatment possibilities for existing protontherapy centres, enabling them for the first time to treat heart patients. | $15.7M / Series A / Jun 27, 2023 | |
Terapet
|
Terapet was founded at CERN by two physicists – Christina Vallgren and Marcus Palm – along with Professor Raymond Miralbell from the Geneva University Hospitals (HUG). They have already proven the feasibility of their concept and are now developing an initial version for market launch. | $2.5M / Seed / Feb 17, 2023 | |
Medyria
|
Medyria is a Swiss medtech startup that engineers technologies for cardiovascular catheter navigation and sensing. They develop a unique guiding and sensing medical device based on proprietary Blood Flow Velocity Sensor technology. The TrackCath System is designed to be cost-effective and safe during EVAR procedures.Medyria's goal is todevelop devices that enable safer and more effective endovascular procedures. It was founded in 2014 and is based in Winterthur, Zurich, Switzerland. | $4M / Series B / Jan 10, 2023 | |
CV Lab
|
CV Lab is the first incubator fully focused on cardiovascular innovation in Europe. It supports the most promising ideas through patenting, prototyping, and proof of concept until they mature enough to give life to a spin-off and meet international capitals. CVLab puts to good use the experience of entrepreneurs and specialists with strongexpertise in biomedical. The company collaborates with experts in the field. CVLab is a lean organization, close to researchers and clinical needs. | Seed / Sep 12, 2016 |
Co-Investors
About Efficient Frontier Investing
Efficient Frontier Investing is an investment firm that specializes in both private and public investment. Efficient Frontier Investing was founded in 2018 and was headquartered in Geneva.
Efficient Frontier Investing Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Caroline Cantele
Head of Funds Operations
|
|||
|
Giovanni Leo
Partner
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Giovanni Leo invest in?
Giovanni Leo invests primarily in Health Care, Medical Device and Medical startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Giovanni Leo's check size?
Giovanni Leo typically joins rounds of $4M–$5.1M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Giovanni Leo participates in.
When did Giovanni Leo last invest?
The most recent investment recorded for Giovanni Leo closed in Sep 2023. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
